Roflumilast (500mg)

Feb 03, 2023

Fluromilast 500 
Roflumilast (500mg) Tablet is used to prevent chronic obstructive pulmonary disease(COPD), group of lung disorders in which the flow of air to the lungs is blocked and chronic bronchitis. It works by opening the airways and makes breathing easier.
Roflumilast (500mg) Tablet can be taken with or without food, but take it at the same time every day to get the most benefit. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you. Do not miss even a single dose, if in any case, you missed a dose, take it as soon as you remember or better to skip the missed dose and continue with regular dosing.  It does not prevent the already started breathing trouble or COPD, hence always carry your medical inhaler with you for an emergency.
The most common side effects of this medicine include headache, weight loss, dizziness, insomnia, and back pain.  If these bother you, or appear serious, let your doctor know. There may be ways of reducing or preventing them. To overcome dizziness, you must avoid driving and attention-seeking activity until you do not know how medicine affects you. If you experienced sudden weight loss, then regular weight monitoring is required.

Steris Healthcare Pvt. Ltd is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have new product in our portfolio. In Last 4 years we are dealing in Chronic Theraphy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufacture at WHO-GMP Approved Plants & We have Legal manufacturing contract with all leading Manufacturer of Inda. Today we have 1000+ Business Franchise Partner in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with the similar pace with the STERIS. Be first to launch like us.  

for more information please contact:
info@sterispharma.com

SHARE WITH